From NY Times
By Stephanie Sauls

The Food and Drug Administration said yesterday that it was moving toward endorsing sale of the morning-after pill without a prescription for women 18 and older, signaling what may be the end of one of the most stubborn health policy debates of the Bush administration.

The agency’s acting commissioner, Dr. Andrew von Eschenbach, asked the drug’s manufacturer, Barr Pharmaceuticals, for a meeting to complete plans that would allow the over-the-counter sale of the emergency contraceptive, called Plan B. In a statement, the F.D.A. said it hoped the process can be wrapped up in a matter of weeks.

While the agency’s letter to Barr was not a final approval, both the F.D.A. and the company expressed optimism about the drug’s future.

Read More Plan B